Results 51 to 60 of about 19,006 (184)

IDIOPATHIC THROMBOCYTOPENIC PURPURA (i.T.P.) [PDF]

Acta Medica Iranica, 1987
The course of t he disorder is acute and chronic.The acute form o f the disease occurs most c ommonly in children , but is seen i n adults as well . The chronic recurrent f orm occurs most o f t e n in women between t wenty and forty years of age.
Sh. MOHAMEDI M ZAMANIANPOUR ML GHASEMI
doaj   +1 more source

Bone marrow examination findings at aga Khan University Hospital, Nairobi [PDF]

, 2010
Objective: To establish the bone marrow examination findings and determine the indication for bone marrow examination. Design: A retrospective audit. Setting: Aga Khan University Hospital, Nairobi.
Malkit, Riyat, Okinda, Nancy
core   +2 more sources

A Difficult‐to‐Manage Case of Primary Idiopathic Erythromelalgia—Case Report

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Erythromelalgia is a rare condition with symptoms of erythema, warmth, and painful extremities exacerbated by warmth and relieved by cooling. Pain management is often challenging. The sodium channel blocker, lacosamide, was most effective in this patient.
Sarah Wide, Rajish S. K. Shil, Bernhard Frank, Viraj Bharambe   +3 more
wiley   +1 more source

Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Vitamin D Supplementation and Hydroxychloroquine: Two Case Reports [PDF]

, 2013
Introduction: Immune thrombocytopenic purpura is thought to be characterized by an immune response against the host’s own platelets. If the thrombocytopenia is severe, patients are initially treated with high-dose steroids.
Bockow, Barry, Bockow, Tamara B
core   +1 more source

Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Aplastic anemia (AA) is a rare bone marrow failure syndrome with pancytopenia, mainly due to immune‐mediated stem cell destruction. First‐line therapy for acquired severe AA ≥ 50 years/non‐severe AA (NSAA) requiring treatment is immunosuppressive therapy with horse anti‐thymocyte globulin, cyclosporine A (CSA), and eltrombopag ...
Sandra M. Frey, Ferras Alashkar, H. Christian Reinhardt, Alexander Röth   +3 more
wiley   +1 more source

Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone

Clinical Case Reports, 2020
Our case highlights the possible coexistence of essential thrombocythemia (ET) and idiopathic thrombocytopenic purpura (ITP), two pathological entities with opposite clinical and laboratory manifestations.
Antonio Carruale, Francesco Longu, Francesca Mura, Giovanni Caocci, Giorgio La Nasa, Claudio Fozza   +5 more
doaj   +1 more source

Trombocitopenia inmune primaria en pacientes de edad avanzada : experiencia en un centro [PDF]

, 2011
Estudi descriptiu dels pacients majors de 60 anys amb diagnòstic de trombocitopènia immune primària en un centre. S'han revisat característiques bàsiques en el moment de l'inici de la malaltia, així com les diferents línies de tractament, resposta ...
López Pavía, María de la Encarnación, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +2 more
core  

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. [PDF]

, 2018
Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder which presents with isolated thrombocytopenia and risk of hemorrhage. While most children with ITP promptly recover with or without drug therapy, ITP is persistent or chronic in ...
Bennett, Carolyn M., Breakey, Vicky R., Brown, Travis, Buchanan, George R., Bussel, James B., Crary, Shelley E., Despotovic, Jenny M., Forbes, Peter W., Geddis, Amy, Grace, Rachael F., Haley, Kristina M., Hege, Kerry, Jeng, Michael, Klaassen, Robert J., Lambert, Michele P., Lorenzana, Adonis, Neier, Michelle, Neufeld, Ellis J., Neunert, Cindy, Pastore, Yves D., Rose, Melissa J., Rothman, Jennifer A., Shimano, Kristin A., Thompson, Alexis   +23 more
core   +1 more source

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

Immunology, Volume 177, Issue 4, Page 736-748, April 2026.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia [PDF]

, 2018
Immune thrombocytopenia (ITP) is characterised by a transient or persistent decrease in platelets accompanied by an increased risk of bleeding, which can have a significant negative impact on patients' health-related quality of life.
Imbach, Paul, Kühne, Thomas
core